DrugPatentWatch Database Preview
Sagent Pharms Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has forty-six approved drugs.
Summary for Sagent Pharms Inc
| US Patents: | 0 |
| Tradenames: | 40 |
| Ingredients: | 39 |
| NDAs: | 46 |
Drugs and US Patents for Sagent Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | DAPTOMYCIN | daptomycin | POWDER;IV (INFUSION) | 208385-001 | Sep 12, 2017 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 204695-001 | Aug 22, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 091458-002 | Jul 28, 2010 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090581-001 | Oct 20, 2015 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090583-003 | Nov 27, 2015 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
